Date
2019Journal
Medicina (Lithuania)Publisher
MDPI AGType
Article
Metadata
Show full item recordAbstract
We present two cases demonstrating the nuances that must be considered when determining if a patient could benefit from low dose computed tomography (LDCT) lung cancer screening. Our case report discusses the available literature, where it exists, on lung cancer screening with special attention to the impact of chronic obstructive pulmonary disease (COPD), and poor functional status. Patients with COPD and concurrent smoking history are at higher risk of lung cancer and may therefore benefit from lung cancer screening. However, this population is at increased risk for complications related to biopsies and lobar resections. Appropriate interventions other than surgical resection exist for COPD patients with poor pulmonary reserve. Risks and benefits of lung cancer screening are unique to each patient and require shared decision-making. Copyright 2019 by the authors.Sponsors
Funding: Author Janaki Deepak has grant funding through National Institutes of Health, Laboratory of Human Carcinogenesis, CCR, NCI-NO2RC-57700.Identifier to cite or link to this item
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85070441771&doi=10.3390%2fmedicina55070364&partnerID=40&md5=caab106a6ed9b1a6384b66a2c5fd6156; http://hdl.handle.net/10713/10418ae974a485f413a2113503eed53cd6c53
10.3390/medicina55070364